Status:
WITHDRAWN
JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Lead Sponsor:
Endologix
Conditions:
AAA
AAA - Abdominal Aortic Aneurysm
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohort...
Eligibility Criteria
Inclusion
- Adult age 21 and older
- Subjects with minimum of 2 year life expectancy
- Subjects have signed the informed consent document
- Subjects with unruptured infrarenal AAA who are assessed by the Investigator to be eligible for endovascular Abdominal Aortic Aneurysm Repair with the trial devices.
- Patient must be able and willing to comply with all required follow-up exams.
Exclusion
- Currently participating in another trial where the primary endpoint has not been reached yet.
- Known allergy to any of the device components
- Pregnant (females of childbearing potential only)
- Known connective tissue disorders
- Known active infection
- Subjects with pre-existing EVAR, i.e., in need of repair/intervention of a previously failed EVAR.
- Patient has other medical, social, or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2030
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05409118
Start Date
December 1 2025
End Date
December 1 2030
Last Update
August 7 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.